Poly Medicure Ltd Stock Price Today (NSE: POLYMED)
Fundamental Score
Poly Medicure Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Poly Medicure Ltd share price today is ₹1537.60, up +1.37% on NSE/BSE as of 17 June 2026. Poly Medicure Ltd (POLYMED) is a Mid-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹19.51K (Cr). The 52-week high for POLYMED share price is ₹2316.60 and the 52-week low is ₹1182.00. At a P/E ratio of 53.89x, POLYMED is currently trading above its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 15.77% and a debt-to-equity ratio of 0.08.
Poly Medicure Ltd Share Price Chart — NSE/BSE Historical Performance
Poly Medicure Ltd share price chart: -10.86% return over the past month. 52-week high ₹2316.60, 52-week low ₹1182.00.
Poly Medicure Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1323.00 | ₹1330.80 | ₹1300.00 | ₹1321.40 | 1.07L (Cr) | |
| ₹1340.10 | ₹1364.80 | ₹1323.30 | ₹1333.90 | 1.36L (Cr) | |
| ₹1329.30 | ₹1397.50 | ₹1318.00 | ₹1349.70 | 4.38L (Cr) | |
| ₹1330.30 | ₹1330.30 | ₹1330.30 | ₹1330.30 | 0.00 (Cr) | |
| ₹1440.00 | ₹1450.00 | ₹1313.00 | ₹1330.30 | 5.60L (Cr) | |
| ₹1500.00 | ₹1500.00 | ₹1428.00 | ₹1439.80 | 5.73L (Cr) | |
| ₹1600.00 | ₹1634.20 | ₹1515.00 | ₹1547.20 | 1.67L (Cr) | |
| ₹1555.10 | ₹1606.20 | ₹1553.70 | ₹1598.20 | 1.21L (Cr) | |
| ₹1465.00 | ₹1563.00 | ₹1461.50 | ₹1550.60 | 2.41L (Cr) | |
| ₹1455.00 | ₹1489.00 | ₹1428.20 | ₹1459.40 | 83.29K (Cr) |
Poly Medicure Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1340.10 | ₹1364.80 | ₹1300.00 | ₹1321.40 | -1.40% | |
| ₹1520.00 | ₹1710.00 | ₹1313.00 | ₹1349.70 | -11.20% | |
| ₹1209.90 | ₹1537.60 | ₹1205.00 | ₹1512.10 | +24.98% | |
| ₹1232.40 | ₹1415.00 | ₹1182.00 | ₹1191.10 | -3.35% | |
| ₹1500.00 | ₹1598.30 | ₹1229.00 | ₹1256.10 | -16.26% | |
| ₹1762.00 | ₹1839.00 | ₹1483.10 | ₹1520.90 | -13.68% | |
| ₹1936.80 | ₹1952.30 | ₹1683.10 | ₹1773.70 | -8.42% | |
| ₹2005.00 | ₹2094.30 | ₹1832.90 | ₹1939.10 | -3.29% | |
| ₹1945.20 | ₹2003.40 | ₹1834.30 | ₹1999.70 | +2.80% | |
| ₹2080.00 | ₹2144.90 | ₹1921.20 | ₹1948.10 | -6.34% | |
| ₹1947.90 | ₹2138.90 | ₹1821.20 | ₹2085.40 | +7.06% | |
| ₹2227.90 | ₹2316.60 | ₹1932.10 | ₹1937.80 | -13.02% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Poly Medicure Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Poly Medicure Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of POLYMED across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (15.77%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (20.08%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (25.83%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (19.44% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (24.88% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (28.38% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (43.09x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (62.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 53.89x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-152.93 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Poly Medicure Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Poly Medicure Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Poly Medicure LtdPoly Medicure L...Selected✓ POLYMED • 531768 | 60.7/100 | ₹1537.60₹1538 | ₹19506.20₹19506.20 | 53.89Average 53.9 Average | 15.77%Good 15.77% Good | 20.08%Excellent 20.08% Excellent | 0.08Excellent 0.1 Excellent | 28.38%Excellent 28.38% Excellent | 19.44%Excellent 19.44% Excellent | 0.18% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 31.7/100 | ₹34.60₹35 | ₹3162.93₹3162.93 | 157.52Average 157.5 Average | 0.70%Poor 0.70% Poor | 1.08%Poor 1.08% Poor | 0.08Excellent 0.1 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 68.7/100 | ₹204.24₹204 | ₹1488.44₹1488.44 | 57.78Average 57.8 Average | 21.88%Excellent 21.88% Excellent | 19.20%Good 19.20% Good | 0.04Excellent 0.0 Excellent | 57.51%Excellent 57.51% Excellent | 9.81%Good 9.81% Good | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 42.1/100 | ₹517.70₹518 | ₹1363.11₹1363.11 | 50.06Average 50.1 Average | 30.08%Excellent 30.08% Excellent | 31.14%Excellent 31.14% Excellent | 0.56Good 0.6 Good | — — | — — | 0.00% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 13.8/100 | ₹210.79₹211 | ₹1224.98₹1224.98 | 59.58Average 59.6 Average | 4.75%Poor 4.75% Poor | 6.91%Poor 6.91% Poor | 0.63Good 0.6 Good | — — | — — | 0.00% |
60.3/100 | ₹173.00₹173 | ₹633.93₹633.93 | 25.77Average 25.8 Average | 36.78%Excellent 36.78% Excellent | 31.12%Excellent 31.12% Excellent | 0.53Good 0.5 Good | 90.06%Excellent 90.06% Excellent | 61.82%Excellent 61.82% Excellent | 0.00% | |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 68.5/100 | ₹396.00₹396 | ₹521.17₹521.17 | 26.18Average 26.2 Average | 18.74%Good 18.74% Good | 25.25%Excellent 25.25% Excellent | 0.00Excellent 0.0 Excellent | 29.49%Excellent 29.49% Excellent | 22.80%Excellent 22.80% Excellent | 0.23% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 61.2/100 | ₹386.05₹386 | ₹354.57₹354.57 | 34.23Average 34.2 Average | 13.58%Average 13.58% Average | 16.35%Good 16.35% Good | 0.43Excellent 0.4 Excellent | 74.11%Excellent 74.11% Excellent | 13.69%Good 13.69% Good | 0.00% |
47.7/100 | ₹190.60₹191 | ₹294.37₹294.37 | 32.71Average 32.7 Average | 13.56%Average 13.56% Average | 18.45%Good 18.45% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 36/100 | ₹276.45₹276 | ₹292.61₹292.61 | 71.19Average 71.2 Average | -1.12%Poor -1.12% Poor | -0.90%Poor -0.90% Poor | 0.03Excellent 0.0 Excellent | — — | 1.98%Average 1.98% Average | 0.00% |
29.6/100 | ₹83.00₹83 | ₹189.41₹189.41 | 15.39Average 15.4 Average | 14.36%Average 14.36% Average | 16.60%Good 16.60% Good | 0.55Good 0.6 Good | — — | — — | 0.51% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Fischer Medical Ventures Ltd share price3162.93 Cr
- Laxmi Dental Ltd share price1488.44 Cr
- OSEL DEVICES LIMITED share price1363.11 Cr
- Tarsons Products Ltd share price1224.98 Cr
- APRAMEYA ENGINEERING LTD share price633.93 Cr
Poly Medicure Ltd PE Ratio History
Historical price-to-earnings ratio for POLYMED — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹34.11 | ₹1773.70 | 52x |
| FY 2024 | ₹26.90 | ₹2615.25 | 97.2x |
| FY 2023 | ₹18.67 | ₹1489.90 | 79.8x |
| FY 2022 | ₹15.27 | ₹897.85 | 58.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Poly Medicure Ltd Dividend History
Annual cash dividends paid by POLYMED — dividend yield 0.18%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹30.34 Cr |
| FY 2024 | ₹28.74 Cr |
| FY 2023 | ₹23.97 Cr |
| FY 2022 | ₹23.92 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Poly Medicure Ltd Quarterly Performance
Latest quarterly metrics for POLYMED — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.68%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
5.02%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.44%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
28.38%
Compounded annual net profit growth over 5 years
Poly Medicure Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for POLYMED — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Poly Medicure Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Poly Medicure Ltd (POLYMED) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Poly Medicure Ltd
About POLYMED (Poly Medicure Ltd)
Poly Medicure Ltd is a dynamic player in the medical equipment and supplies sector, dedicated to advancing healthcare through innovative and reliable medical devices. The company h...as carved a niche for itself by specializing in the development, production, and distribution of a diverse portfolio of medical products. These products are meticulously engineered to meet the evolving needs of patients and healthcare providers, demonstrating a commitment to improving patient outcomes and streamlining clinical workflows. Poly Medicure is driven by a core philosophy of quality, precision, and customer-centricity, evident in its adherence to stringent manufacturing standards and its dedication to fostering strong relationships with its partners in the medical community. The company's extensive product line reflects its dedication to comprehensive healthcare solutions. Its offerings encompass a wide range of devices crucial for various medical procedures and therapies. These include sophisticated infusion therapy systems designed for precise and controlled medication delivery, as well as vital tools for critical care settings, providing clinicians with the resources they need to manage complex patient conditions effectively. Beyond these core areas, Poly Medicure also supplies essential devices for diagnostics, and specialized equipment for surgical applications, contributing to a holistic approach to patient care. Poly Medicure's commitment extends beyond product development to include a robust global distribution network, ensuring that its medical devices reach healthcare facilities and practitioners around the world. With a strong presence in both domestic and international markets, the company actively collaborates with hospitals, clinics, and other healthcare providers to deliver the latest advancements in medical technology. This global reach, coupled with its dedication to quality and innovation, positions Poly Medicure as a trusted partner in the medical community and a significant contributor to the advancement of healthcare worldwide.
Company Details
Key Leadership
Corporate Events
POLYMED Share Price: Frequently Asked Questions
What is the current share price of Poly Medicure Ltd?
Poly Medicure Ltd (POLYMED) trades at ₹1537.60 on NSE and BSE. Market cap ₹19.51K (Cr). Educational data only.
What is the P/E ratio of Poly Medicure Ltd?
Poly Medicure Ltd has a P/E of 53.89x vs industry average 47.87x.
What is the Bull Run score for Poly Medicure Ltd?
Poly Medicure Ltd has a Bull Run score of 60.7/100 based on 25+ financial parameters.
Does Poly Medicure Ltd pay dividends?
Poly Medicure Ltd has a dividend yield of 0.18%. Past dividends don't guarantee future payments.
What is the ROE of Poly Medicure Ltd?
Poly Medicure Ltd has ROE of 15.77%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Poly Medicure Ltd?
Poly Medicure Ltd has debt-to-equity of 0.08.
Is Poly Medicure Ltd a good investment?
Bull Run gives Poly Medicure Ltd a score of 60.7/100. This is not investment advice — consult a SEBI-registered advisor.